Quantitative proteomic analysis of CKD urine samples

ABSTRACT: Urinary proteomics studies have primarily focused on identifying markers of chronic kidney disease (CKD) progression. Here, we aimed to specify CKD-related injury markers through proteomics analysis in urine of patients with CKD. Label-free quantitative proteomics analysis based on liquid chromatography-tandem mass spectrometry was performed on urine samples obtained from 6, 9, 11, and 10 patients in health control, CKD stage 1, 3 and 5, respectively.

INSTRUMENT(S): Q Exactive Plus

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Dohyun Han  

PROVIDER: MSV000087635 | MassIVE | Tue Jun 15 19:05:00 BST 2021

SECONDARY ACCESSION(S): PXD016433

REPOSITORIES: MassIVE